Donor transfer of pulmonary coccidioidomycosis in lung transplantation.
Transplant recipients living in endemic areas are at high risk of aerosol-transmitted fungal infections because of environmental exposure while on immunosuppressive drugs, as well as reactivation of latent infection from either the patient's or the donor's organs. The latter may account for early development of coccidioidomycosis after transplantation. We describe a case of pulmonary coccidioidomycosis in a lung transplant recipient who acquired the infection from the donor lung and presented with fulminant pneumonia in the immediate postoperative period.
Tripathy
Uttam
U
Division of Cardiothoracic Surgery, University of California, San Diego, USA.
Yung
Gordon L
GL
Kriett
Jolene M
JM
Thistlethwaite
Patricia A
PA
Kapelanski
David P
DP
Jamieson
Stuart W
SW
D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D003047:Coccidioidomycosis / Q000188:drug therapy / Q000209:etiology*; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D008172:Lung Diseases, Fungal / Q000188:drug therapy / Q000209:etiology*; D016040:Lung Transplantation / Q000009:adverse effects*; D008297:Male
D000935:Antifungal Agents; D015725:Fluconazole